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Lipopolysaccharides (LPS)1 from Gram-negative bacteria or the lipid A component 
isolated  from LPS are  potent  stimulators of murine B  lymphocytes in  vivo and  in 
vitro. In the absence of antigens, LPS initates  proliferation and differentiation of B 
lymphocytes, leading  to  the  synthesis  and  secretion  of nonspecific IgM polyclonal 
antibodies (1-3). As a result, mice also develop several types of autoantibodies such as 
anti-DNA antibodies, rheumatoid factors (RF)  and thymocytotoxic antibodies after 
the injection of LPS (4-8). 
Although  substantial  numbers  of IgM  antibodies  are  induced,  generally  their 
synthesis is transient and short-lived (7, 9). Some IgG production has been documented 
as well, but only in an in vitro system (10). Our study has been designed to assess this 
response  further by comparing the capacity of various LPS preparations  to induce 
formation of IgM and IgG polyclonal antibodies, including several types of autoanti- 
bodies  in  adult  normal  mice  and  athymic  nude  (nu/nu)  mice.  The  experiments 
showed that only lipid A-rich, polysaccharide-free LPS from Salmonella minnesota R595 
induced long-lasting production of both IgM and IgG in both normal and athymic 
nude mice. In addition, normal mice made only the IgG2b and IgG3 subclasses in the 
response  to  the  injection  of R595  LPS,  but  athymic  nude  mice  formed  all  four 
subclasses of IgG. 
Materials and Methods 
Mice.  All mice used  in this study were 6-10 wk old. C57BL/6, C3H/St, and C3H/HeJ 
mice  were  obtained  from  the  mouse  breeding  colony of the  Scripps  Clinic  and  Research 
Foundation, La Jolla, Calif. Congenitally  athymic nude (nu/nu) and heterozygous littermate 
(nu/+) C57BL/6 mice were kindly provided by Dr. D. E. Parks (Scripps Clinic and R~earch 
Foundation).  Blood samples were collected by orbital  sinus puncture and sera were stored at 
-20°C until  use. 
LPS.  LPS purified from X minnesota R595 (R595 LPS), Escherichia coli 0111  :B4, E. coil 055: 
* Supported in part by U. S. Public Health Service grants AI-07007,  N01-CP-71018,  CA-16600, AM-AI 
25733-04C01, and AM 26574-01 and the Cecil H. and Ida M. Green Research Endowment. Publication 
No. 2216 from the Immunology  Department, Scripps Clinic and Research Foundation, La Jolla, Calif. 
~Abbreviations used in  this paper: BBS, borate-buffered saline; BSA, bovine serum albumin; Con A, 
concanavalin A;  DNP, dinitrophenyl; LPS, lipopolysaccharide(s); 2-ME, 2-mercaptoethanol; MEM, 
minimal essential medium; PFC, plaque-forming  cell(s); PII-LPS,  fraction II LPS extracted from Escherichia 
coli 011 l :B4 with aqueous  phenol; R595 LPS, LPS extracted from  Salmonella  minneosta  R595; RF, rheumatoid 
factor; SRBC, sheep erythrocytes;  ssDNA, single-stranded DNA; TNP, trinitrophenyl. 
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B5, E. coli K235, and Salmonella typhimurium were generously provided by Dr. D. C. Morrison 
(Department  of Microbiology, Emory University School of Medicine, Atlanta, Ga.). E.  coli 
0111 :B4 extracted with aqueous phenol (11) was further fraetionated by Sepharose 4B column 
chromatography (12) and fraction II of this preparation (designated PII-LPS) was used in this 
study because it exhibited more potent activity as polyclonal B cell activators in vivo compared 
with fraction I LPS (13). R595 LPS extracted as described by Galanos et al. (14) was solubilized 
by sonication in 0.1% triethylamine and dialyzed against saline. All the LPS preparations were 
diluted to the desired concentrations with saline and injected intraperitoneally in a final vol of 
0.2 ml. 
Immunologic Reagents.  Murine  IgG was purchased from  Miles Laboratories, Inc., Elkhart, 
Ind. Murine myeloma proteins IgG1 (MOPC 21), IgG2a (UPC  10), IgG2b (MOPC  195), IgG3 
(Y5606), and IgA (TEPC  15) were obtained from Litton Bioneties, Kensington, Md. Murine 
myeloma  proteins,  ABPC  22  (g,K) and  MOPC  104E  (g,hl)  were  prepared  as  described 
previously (7). 
Anti-murine IgM antibodies were raised in goats repeatedly injected with MOPC  104E and 
were affinity purified on insolubilized ABPC 22. A polyvalent anti-murine Ig (IgG plus IgM 
plus IgA) was prepared by immunizing a rabbit with murine Fr II (Miles Laboratories, Inc.). 
Monospecific rabbit  anti-murine  IgG,  IgG1,  IgG2a,  IgG2b,  IgG3,  and  IgA  antisera  were 
obtained from Litton Bionetics. 
Highly polymerized calf thymus DNA (type V) was purchased from Sigma Chemical Co., 
St. Louis, Mo. Single-stranded DNA (ssDNA) was prepared by heating native DNA (0.5 mg/ 
ml) at 100°C for 10 rain, then transferring it immediately to an ice bath. Bovine serum albumin 
(BSA; Calbioehem-Behring Corp., American Hoechst Corp., San Diego, Calif.) was conjugated 
with dinitrophenyl (DNP) in a reaction with dinitrobenzenesulfonate, yielding a hapten:protein 
ratio of 20:1  (15). 
Radiolabeling Procedures.  Anti-murine IgM was labeled with radioactive iodine (125I) accord- 
ing to the lactoperoxidase procedure of David and Reisfeld (16). ssDNA was labeled with azsI 
by the method of Commerford (17).  DNP20-BSA  was iodinated by the chloramine T  method 
(18).  x~I-labeled PII-LPS and R595 LPS (19) were kindly provided by Dr. R. J. Ulevitch and 
Dr. A. R. Johnston (Scripps Clinic and Research Foundation). 
Hemolytic Plaque Assay.  To measure polyelonal antibody responses, spleens of LPS- or saline- 
injected  mice  were  removed,  placed  into  chilled  minimal  essential  medium  (MEM)  and 
disrupted with a loose-fitting glass homogenizer. After brief sedimentation, cells in the super- 
nates were washed twice in cold MEM and suspended in MEM. The modified Jerne hemolytic 
plaque-forming  cell  (PFC)  assay  (20)  was  used  to  detect  PFC.  Target  cells  were  sheep 
erythroeytes (SRBC; Colorado Serum Co., Denver, Col.) heavily conjugated with the hapten 
trinitrophenyl (TNP) by reacting with a solution containing 2,4,6-trinitrobenzene sulfonic acid 
(ICN Nutritional Bioehemicals, Cleveland, Ohio) (21). 
Assays of lgM, IgG, and lgA Levels in Sera.  Solid-phase radioimmunoassay was performed to 
assess the serum levels of IgM as described previously (7).  100/tl of 1 #g/ml anti-IgM in borate- 
buffered  saline  (BBS),  pH  8.4,  was  used  to  coat  wells of flexible microtiter plates  (Cooke 
Engineering Co., Alexandria, Va.) for 5 h at room temperature. After they were washed three 
times with BBS, the wells were further coated with 0.5%  solution of BSA before 100 pl of a 
I:10,000 dilution of test serum samples in BBS that contained 2% BSA was added. The plates 
were then incubated overnight at 4°C and washed five times with BBS, after which 1 ng of l~5I- 
labeled  anti-murine  IgM  in  BBS  that  contained  2%  BSA  was  added.  These  plates  were 
incubated  another  5  h  at  4°C  and  washed,  after which  individual wells were cut  out  for 
counting. A standard curve was established by using the two murine IgM myeloma proteins 
ABPC 22 and MOPC  104E. 
Serum concentrations of IgG, their subclasses, and IgA were determined by radial immu- 
nodiffusion in agar by using monospecific rabbit anti-murine 7S IgG, anti-IgG1, anti-IgG2a, 
anti-IgG2b, anti-IgG3, or anti-IgA antisera according to the method of Mancini et al. (22). 
Assays of Anti-DNP Antibodies, RF, Anti-ssDNA, and Anti-LPS Antibodies. 
ANTx-DNP ASSAY.  Serum levels of IgM anti-DNP antibodies were measured as described 
previously (23)  with a  radioimmunoassay in which lzSI-DNPzo-BSA  was the antigen. Results 
are expressed as a percentage of 10 ng xzSI-DNP2o-BSA precipitated specifically after correction 326  IgG  POLYCLONAL ANTIBODY RESPONSE BY  LIPOPOLYSACCHARIDES 
for nonspecific precipitation in pooled sera of normal mice. To determine IgM and IgG anti- 
DNP activity in sucrose  density gradients,  100 #1  of each  fraction was  incubated with 125I- 
DNP20-BSA in the presence of 5/tl of pooled normal mouse serum for use as a carrier protein. 
After incubation at  4°C overnight, goat  anti-murine IgM antisera (sufficient  to  precipitate 
>95% of the IgM) or rabbit anti-murine  Ig antisera (sufficient  to precipitate >95% of the IgG) 
was added as indicated. 
IgM RF ASSAY.  Serum levels of IgM RF were measured by a solid phase radioimmunoassay 
with murine IgG used as the antigen. The details of this assay were described previously (7). 
ANTI-ssDNA ASSAY.  Serum ssDNA-binding activity was determined with a modified Farr 
DNA binding  radioimmunoassay (24). To determine only IgG anti-DNA activity, test sera were 
incubated with 125I-ssDNA in the presence of 2-mercaptoethanol (2-ME; final concentration 
0.1  M), which completely inactivated the IgM anti-DNA activity without affecting IgG anti- 
DNA  activity. The  results are  expressed  as  a  percentage of 20  ng 125I-ssDNA precipitated 
specifically.  To determine IgM and IgG anti-DNA activity in sucrose density gradients, 100/xl 
of each fraction was incubated with ~2~I-ssDNA  in the presence of 5/xl of pooled mouse serum. 
ANTI-LPS ASSAY.  Antibodies against R595 LPS were measured with a radioimmunoassay 
using ~25I-R595 LPS as antigen. 0.1 ml of heat-inactivated serum diluted 1:10 in BBS or 0.1 ml 
of sucrose  gradient fractions was mixed with 0.05 ml of 125I-LPS (10 ng). After incubation at 
37°C for 2 h, 0.2 ml of rabbit anti-murine Ig antisera (sufficient  to precipitate >95% of the 
IgM and IgG) was added to precipitate x25I-LPS bound to antibodies. Results are expressed  as 
a percentage of 125I-LPS precipitated specifically after correction for nonspecific precipitation 
in pooled sera of normal mice. 
Sucrose Density-Gradient Ultracentrifugation.  100/xl  ofsera was layered on a 5-20% linear sucrose 
density gradient in 0.01 M  phosphate-buffered saline, pH  7.0. Samples were centrifuged at 
33,000 rpm for  15 h at 4°C with a SW60 rotor in a Beckman L-75 ultracentrifuge (Beckman 
Instruments, Inc., Fullerton, Calif.). The positions of IgG and IgM were established by using 
radioactive markers in gradients divided into 14 fractions. 
Lymphocyte Cultures and Measurement of DNA Synthesis.  Spleens removed aseptically from test 
mice were dispersed by gentle teasing with forceps  into RPMI-1640 medium (Grand Island 
Biological  Co.,  Grand  Island,  N.  Y.).  Cell  aggregates  were  disrupted  by  passing  the  cell 
suspensions through a 26-gauge needle. Single cell suspensions were washed twice with medium, 
and the number of viable cells were counted. They were then suspended at a concentration of 
I0  v viable nucleated cells/ml in RPMI-1640 medium which was  supplemented with  1%  L- 
glutamine (200 mM),  100 U/ml penicillin, and 100/~g/ml streptomycin. 100 ~tl of spleen cell 
suspension and  100 #1  of various concentrations of LPS or concanavalin A  (Con A;  Sigma 
Chemical Co.) in medium were incubated in microcuhure plates (Falcon Labware, Div. Becton, 
Dickinson & Co.,  Oxnard, Calif.)  in a  5%  CO2  atmosphere at  37°C  for  72  h.  24  h  before 
harvesting, 10 #1 of medium that contained 1/xCi of methyl-[3H]thymidine (5 Ci/mmol sp act; 
Amersham Corp., Arlington Heights, Ill.) was added. Cultures were harvested with a Brandel 
Cell Harvester (model M24V; Biological Research and Developmental Laboratories, Rockville, 
Md.) 
Results 
Long-Lived IgM Polyclonal Antibody Formation After Injection ofR595 LPS.  The abilities 
of two different LPS preparations, PII-LPS from E. colt 0111 :B4 and R595 LPS from 
S. minnesota, to induce polyclonal antibody formation were assessed in vivo by injecting 
C57BL/6 mice intraperitoneally with the range of doses listed in Table I. 3 d  later, 
polyclonal antibody production in the spleens of these animals was measured by the 
hemolytic plaque assay with TNP-SRBC as  target  cells.  Injection of  1 /~g of R595 
LPS or 10/~g of PII-LPS significantly  stimulated polyclonal antibody synthesis (Table 
I). Maximum response was seen with a  dose of 10 ~g R595 LPS or 50/xg PII-LPS. 
The kinetics of polyclonal antibody production in spleens and in sera were compared 
in  mice  injected  with  50  #g  of  either  R595  LPS  or  PII-LPS.  In  spleens,  both 
preparations markedly increased the number of anti-TNP PFC, with the maximum SHOZO  IZUI,  ROBERT A.  EISENBERG, AND FRANK J.  DIXON 
TABLE  I 
Polyclonal Anti- TNP PFC Responses in Spleens of Mice Injected with LPS 
LPS*  Amount  PFC/106  spleen cells  PFC/spleen 
R595 LPS 
PII-LPS 
#g 
0.01  20 ±  8:[:  2,020 ±  790 
0.1  28 ±  7  2,525 ::t: 647 
1  56 ± 6  3,840 +  1756 
10  293 ±  11  16,851 +  1276 
50  257 ± 41  20,331 ±  1076 
1  20 ±  2  1,733 +  230 
10  40 ±  3  2,751 ±  261 
50  254 ±  14  15,127 ::t: 5479 
100  279 ±  60  19,917 ±  4402 
Saline  16 ±  4  1,616 ±  312 
* LPS was injected intraperitoneally into C57BL/6 mice and anti-TNP PFC 
in spleens were measured 3 d after the injection. 
:~ Mean of five mice ±  1 SD. 
TABLE  II 
Kinetics of Polyclonal Anti- TNP PFC Responses in Spleens of Mice Injected with 
LPS 
327 
Days after 
injection 
Anti-TNP PFC 
R595 LPS*  PII-LPS* 
1 
3 
5 
8 
15 
30 
36+ 20:]:  (1,416 ±  604)§  16 ±  4  (982 ±  230) 
286+72  (21,107±5,411)  261+71  (15,375±5,077) 
101 ±  19  (16,328 ±  5,350)  51 +  14  (6,262  ±  1,313) 
86 ±  22  (7,484  ±  2,715)  23 ±  3  (1,675  ±  331) 
80 ±  21  (6,276  ±  2,790)  19 ±  7  (1,350  ±  624) 
37 ±  13  (4,360  ±  1,134)  12 ±  7  (1,086  ±  547) 
* 50/~g of R595 LPS or PII-LPS was injected intraperitoneally into C57BL/6 mice. 
:[: Mean anti-TNP PFC/I0  n spleen cells of five mice +  1 SD. Mean values (+1 SD) of 
saline-injected control mice were 13 +  5, 
§ Mean anti-TNP PFC/spleen.  Mean  values (+1  SD)  of control mice were 957  ± 
494. 
measurable  on the 3rd d  (Table II). On  the 8th  d, the numbers  of anti-TNP  PFC  in 
mice injected with PII-LPS were only slightly elevated above values of saline-injected 
control  mice,  and  after  30  d,  spleen  cells  from  these  mice  were  no  different  from 
normal  spleen cells in this respect.  On  the other hand,  numbers  of anti-TNP  PFC  in 
spleens of mice injected with R595  LPS remained  abnormally  high, even after 30 d. 
Polyclonal antibody responses to the injection of LPS were assessed in sera by using 
radioimmunoassays  to measure the total levels of IgM and  IgM anti-DNP  antibody. 
Both  these parameters  were increased  at  4  d  after injection of each type of LPS and 
peaked  on  the  8th  d  (Fig.  1).  At  peak  responsiveness,  serum  levels of IgM  were  10 
times higher than saline-injected controls in mice that received R595 LPS and 4 times 
higher in those that  received PII-LPS.  In mice injected with PII-LPS, serum concen- 
trations of polyclonal antibodies dropped  rapidly and were not significantly different 328  IgG POLYCLONAL  ANTIBODY  RESPONSE  BY  LIPOPOLYSACCHARIDES 
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F'IC.  l.  IgM formation after a single injection of LPS and comparison with the capacity of LPS to 
induce the production of anti-DNP, IgM-RF, and anti-ssDNA antibodies. 50 #g of R595  LPS or 
PII-LPS were injected  intraperitonea[[y, into C57BL/6  mice on day 0.  Each  point represents the 
mean value of seven mice.  Vertical bars represent the limits of 1 SD. 
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FI6.  2.  Serum concentrations  of ]gG  in  C57BL/6  mice  injected  with  R595  LPS,  PII-LPS,  or 
saline.  50 #g of each LPS were injected intraperitoneally on day 0. Each point represents the mean 
value of seven mice.  Vertical bars represent the limits of l SD. 
from those of control mice by the 22nd d. However, mice injected with R595 LPS still 
had high levels of IgM and anti-DNP antibodies even 2 mo after the injection. Serum 
concentrations of IgM in these mice were approximately seven times higher at 30 d 
and four times at 60 d than those of control mice. 
Because  LPS  induces  the  formation of several  types of IgM autoantibodies  as  a 
result of polyctonal activation of B cells  (4-8), the kinetics of two types, IgM RF and 
anti-ssDNA antibodies,  were studied  in  mice  injected  with  R595  LPS or PII-LPS. 
Both  autoantibody  responses  were  kinetically  similar  and  peaked  8  d  after  the SHOZO  IZUI,  ROBERT  A.  EISENBERG,  AND  FRANK J.  DIXON  329 
injection of each LPS (Fig. 1). Again, R595 LPS, but not PII-LPS, evoked long-lasting 
production of these autoantibodies similar to the polyclonal antibody response. 
IgG Polyclonal  Antibody Formation After Injection ofR595 LPS.  The possible production 
of IgG polyclonal antibody was  investigated in  mice after injection of 50/xg R595 
LPS or PII-LPS. Serum levels of IgG were measured by radial immunodiffusion using 
antisera specific for gamma chains.  At this dose, PII-LPS never induced significant 
production of IgG at any time point  (Fig. 2).  R595 LPS, on the other hand, caused 
an increased serum IgG beginning day 8 after injection, peaking at levels five times 
controls on day 15, and persisting up to day 60. In an additional assay, we examined 
the production of IgA in sera of mice injected with R595 LPS, but found no significant 
increase at any time during the course of these experiments (data not shown). 
To investigate whether IgG induced by LPS was polyclonal antibody, production 
of 2-ME-resistant IgG anti-ssDNA antibody was followed by using a  modified Farr 
DNA binding radioimmunoassay. 4 d after injection with R595 LPS, test animal sera 
had only 2-ME-sensitive anti-ssDNA antibodies, but by the 8th d 2-ME-resistant anti- 
ssDNA antibody activity began to increase significantly until it peaked on day 15, in 
a  time-course similar to that of total IgG production (Fig. 3). At the peak response, 
~50% of DNA-binding activity was  resistant  to the treatment of 2-ME.  Sera from 
mice injected with PII-LPS did not exhibit significant ssDNA-binding activity in the 
presence of 2-ME. 
To confirm further that R595 LPS induced IgG polyclonal antibodies, the immu- 
noglobulin classes of anti-ssDNA and anti-DNP antibodies were analyzed by sucrose 
density-gradient ultracentrifugation. 8 d  after injection, the animals' sera contained 
a  large peak of anti-ssDNA and anti-DNP antibodies in the  19S position (IgM)  and 
a  small  peak  in  the  7S  position  (IgG)  (Fig.  4).  By  day  15,  the  7S  peaks  were 
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Fro.  3.  Serum gsDNA binding-activity in the presence (0) or absence (O) of 2-ME after a  single 
injection of R595 LPS or PII-LPS. 50/tg of each LPS was injected intraperitoneally into C57BL/6 
mice on day 0.  Each point represents the mean value of seven mice. Vertical  bars represent the 
limits of 1 SD. 
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Fie.  4.  Ig class analysis  of anti-DNP and anti*ssDNA antibodies induced by R595  LPS.  Pooled 
sera from seven C57BL/6 mice were obtained 8 or 15 d after the injection  of 50/zg R595 LPS and 
were fractionated by sucrose density-gradient ultracentrifugation. DNP- and ssDNA-binding activ- 
ities of each gradient fraction were determined by radioimmunoassays.  Arrows indicate the position 
of markers. 
TABLE  III 
Lack of Response to Injection ofR595 LPS in C3H/HeJ Mice 
Strains  Treatment  IgM  IgG 
Anti-DNA 
2-ME  Total  resistant 
#g/ml  mg/ml  % 
C3H/HeJ  R595 LPS*  470 ± 90:~  6.6 ±  1.0  4.6 ±  0.5  0.4 ± 0.4 
Saline  420 ±  10  6.5 ±  1.4  2.4 + 0.2  0.5 ±  0.2 
C3H/St  R595 LPS*  3,370 ±  620  15.0 +  3.3  24.7 ±  3.7  14.8 ±  2.1 
Saline  410 +  140  5.3 ± 0.9  2.4 ±  1.0  0.3 ±  0.7 
* 50 #g R595 LPS was injected intraperitoneally on day 0. Serum levels of IgM and IgG were determined 
on day 8 and day 15, respectively. Serum DNA-binding activity was determined on day 15. 
:~ Mean of seven mice +  1 SD. 
substantially larger  than  the  19S  ones.  The  presence of IgG  antibodies specific for 
R595  LPS  in  these  sera  or  in  their  gradient  fractions  was  then  examined  by 
radioimmunoassays. However, neither the sera nor their gradient fractions exhibited 
significant anti-R595 LPS activity during the experiments. 
The ability of R595 LPS to induce polyclonal IgG antibodies was studied in C3H/ SHOZO IZUI,  ROBERT A.  EISENBERG, AND  FRANK J.  DIXON  331 
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Fzo. 5.  Serum levels of IgM and  IgG in  C57BL/6  athymic  nude  (nu/nu)  and  heterozygous 
(nu/+) mice after a single injection of R595 LPS. 50 #g of R595 LPS was injected intraperitoneally 
on day 0. Each point represents the mean value of seven mice. Vertical bars represent the limits of 
1  SD. 
HeJ mice because of their known resistance to several biologic effects of LPS (25-29). 
The LPS-low-responder C3H/HeJ  mice and LPS-high-responder C3H/St  mice were 
injected with 50 #g of R595 LPS. As a  control, similar groups of mice were injected 
with  saline.  The  LPS-resistant  C3H/HeJ  mice showed  no increased  serum  IgM or 
IgG nor any anti-ssDNA antibodies  within  15 d  after injection of R595  LPS at  the 
dose  used,  whereas  LPS-responder  C3H/St  mice produced  a  significant  amount  of 
IgM and IgG polyclonal antibodies  in the same situation  (Table III). 
The effect of LPS on the polyclonal IgG production was studied  in athymic nude 
mice.  Homozygous  (nu/nu)  nude  C57BL/6  mice  and  their  heterozygous  (nu/+) 
littermates were injected with 50 #g of R595 LPS. Serum IgG and IgM were similarly 
increased  in  both  groups on days 4, 8,  15,  and  24  (Fig.  5).  In addition,  nude  mice 
developed as much total and  2-ME-resistant  anti-ssDNA antibodies  as heterozygous 332  lgG POLYCLONAL  ANTIBODY  RESPONSE  BY  LIPOPOLYSACCHARIDES 
TABLE IV 
Serum DNA-binding Activity in C57BL/6 Nude Mice after Injection ofR595 
LPS 
Genotype  Treatment 
Anti-DNA$ 
Total  2-ME Resistant 
% 
nu/nu  R595 LPS*  26.4 :t: 3.8§  12.4 ±  1.9 
Saline  1.7 ± 0.8  -0.1 + 0.3 
nu/+  R595 LPS*  28.6 ± 3.7  10.4 ± 2.6 
Saline  0.2 ±  1.3  -0.3 ±  1.1 
* 50 ~g R595 LPS was injected intraperitonealty on day 0. 
$ Serum DNA-binding activity was determined on day 15. 
§ Mean of seven mice ±  1 SD. 
TABLE V 
Serum lgM and lgG Levels in C57BL/6 Mice after Injection of LPS 
LPS*  Amount  IgM$  IgG:]: 
#g  t~g/rn!  mg/ml 
R595 LPS  1  500 ±  140§  4.67:1:0.82 
5  670 ± 200  8.25:1:1.61 
10  980 ± 460  9.95 + 2.97 
50  2,260 ± 460  22.25 ± 4.08 
100  2,280 ± 520  23.04 ± 3.96 
PII-LPS  50  500 ±  190  4.73 ± 0.29 
100  540 +  100  4.91 ::t: 1.17 
Saline  100 + 30  4.77:1:0.47 
* Various doses of R595 LPS or PII-LPS were injected intraperitoneally into 
C57BL/6 mice on day 0. 
$ Serum  levels of IgM  and  IgG  were determined  on  day  8  and  day  15, 
respectively. 
§ Mean of five mice -1- 1 SD. 
mice (Table IV). Sucrose density-gradient analysis of sera from nude mice confirmed 
increased amounts of both  19S and  7S anti-ssDNA and anti-DNP antibodies. 
The possible differentiation of T  ceils in  nude  mice injected with R595  LPS was 
examined by  determining whether spleen ceils from  these  mice responded  to the T 
cell mitogen Con A.  Spleen cells from  nude  mice tested  7 or  14  d  after  R595  LPS 
injection and from control nude mice failed to respond to Con A  at any dose. 
Comparison of Doses and Types of LPS in the Induction of IgG.  To establish optimally 
effective doses of LPS for IgG production, C57BL/6 mice were injected with  1-I00 
/xg/mouse of R595 LPS or PII-LPS. The polyclonal IgG response to injection of R595 
LPS was dose-related in that  serum IgG concentrations increased significantly after 
injections >5  btg R595  LPS  and  were highest  in  response  to  >50 ~g  (Table V).  In 
contrast,  PII-LPS,  even  at  a  dose  of  100  /tg,  could  not  induce  a  detectable  IgG 
polyclonal antibody response. Table V  also shows that the dose-response relationship 
for IgG production was remarkably parallel to that for IgM. In addition, there was a SHOZO  IZUI,  ROBERT  A.  EISENBERG,  AND  FRANK J,  DIXON  333 
significant correlation between IgM and IgG in individual samples of sera (r ffi 0.890; 
P <  0.001). 
These differences in  the capabilities of R595  LPS and  PII-LPS to induce IgG 
polyclonal antibody may be  related  to  their  different degrees  of localization in 
lymphoid organs, particularly the spleen.  However, we found no clear difference in 
LPS remaining in spleens at 2, 5, 8, and 15 d after the injection of radiolabeled R595 
LPS or PII-LPS; -0.1% of injected PI]-LPS and slightly less R595 LPS was present 
in the spleens throughout the period of the observation. In addition, radiolabeled and 
unlabeled R595 LPS induced IgG polyclonal antibody production equivalently. 
The ability of various preparations of LPS to induce IgG polyclonal antibodies was 
tested. C57BL/6 mice were injected intraperitoneally with the same amount (50 ~g) 
of R595 LPS or LPS from E. coli 011 l:B4, E. coli K235, E. coli 055:B5, or S. typhimurium. 
Although all the LPS preparations induced significant IgM responses, none except 
the lipid A-rich and polysaccharide-free R595  LPS provoked substantial IgG poly- 
clonal antibody responses (data not shown). It should also be noted that the concen- 
tration of serum IgM induced by R595 LPS was two to four times higher than those 
induced by other preparations of LPS. 
Subclass Restriction  of Polyclonal IgG Antibody  Induced by R595 LPS.  We next deter- 
mined whether R595 LPS could stimulate the formation of all the IgG subclasses. For 
this purpose, normal (+/+ or nu/+) and athymic nude (nu/nu) C57BL/6 mice were 
injected with 50 pg R595 LPS, and total serum IgG for each subclass was determined 
8-30 d later. In sera from euthymic C57BL/6 mice, either +/+ or nu/+, R595 LPS 
greatly increased the amounts of IgG2b and IgG3  with kinetic patterns that were 
identical to those of total IgG production. At the peak response  (on day 15), serum 
levels of  IgG2b and IgG3 were approximately 6 times and 30 times higher, respectively, 
than those of control mice  (Table VI).  However, the concentrations of IgG 1 and 
IgG2a did not change. In contrast, R595  LPS induced the formation of all the IgG 
subclasses in athymic nude (nu/nu) mice. The abnormally low values of IgG1  and 
IgG2a in the nu/nu saline-injected controls were markedly increased to levels approx- 
imating those of saline or LPS-injected nu/+ and +/+ mice.The levels of IgG2b and 
IgG3 were similar in athymic and euthymic saline-injected controls, and these levels 
were increased equally by LPS injection in all groups. 
TABLE VI 
IgG Subclass Produced in Response to R595 LPS in Normal (+/+  or nu/ + ) and Athymic (nu/nu) 
C57BL/6 Mice 
Genotype  Treatment  IgG 1  IgG2a  IgG2b  IgG3 
+/+  R595 LPS  1.89 ±  0.44*  2.23 ±  0.29  6.47  ±  1.26  6.24  ±  1.76 
+/+  Saline  1.81 ±  0.53  2.33 ±  0.22  1.09 ±  0.04  0.17  ±  0.08 
nu/+  R595 LPS  1.71 ±  0.36  2.09 ±  0.19  5.93  ±  1.01  5.80  ±  0.84 
nu/+  Saline  1.65 ±  0.60  2.20 ±  0.22  1.14 ±  0.58  0.19 ±  0.11 
nu/nu  R595 LPS  1.94 ±  0.50  1.40 ±  0.22  6.16  +  0.86  5.76 ±  0.91 
nu/nu  Saline  <0.05  0.24  ±  0.02  1.53 :l: 0.71  0.67  ±  0.26 
* Serum concentrations of each IgG subclass in C57BL/6 mice were determined  15 d after the injection of 
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Discussion 
In these experiments, we have examined effect of the lipid A-rich, polysaccharide- 
free R595 LPS on polyclonal antibody formation in mice. R595 LPS had a remarkably 
greater capability to stimulate B lymphocytes in vivo than the four other preparations 
of polysaccharide-containing LPS  with  which  it  was  compared.  First,  R595  LPS 
induced accelerated and prolonged production of IgM in various strains of normal 
mice as well as in athymic nude mice. At the peak response on day ~, their sera had 
~4 times more [gM than mice injected with other preparations of LPS and ~20 times 
more  than  saline-injected  control  mice.  In  addition,  mice  receiving  R595  LPS 
produced increased amounts of IgM even 2 mo after the injection, but the other LPS 
preparations induced no activity detectable after 3 wk. Second, R595 LPS stimulated 
B cells to produce IgG not only in adult normal mice but also in athymic nude mice 
in vivo. The increased IgG synthesis, which is preceded by increased IgM production, 
peaked  15 d after injection with levels reaching about five times control. 
Several lines of evidence confirm that IgG in addition to IgM is indeed induced by 
R595 LPS. First, the radial immunodiffusion assay for IgG was completely negative 
with immunoglobulins of other classes (Materials and Methods). Second, some of the 
specific  antibody  activity  induced  by  R595  LPS  sediment  as  7S  IgG  in  sucrose 
gradients and is resistant to 2-ME. Finally, the kinetics of IgG induction, measured 
by  radial  immunodiffusion  or  2-ME  resistance  of specific  antibody  activity,  was 
clearly distinguishable from that of IgM formation. 
The IgG induced by R595 LPS was not antibody specific for R595 LPS because no 
anti-R595 LPS antibodies were detectable. Therefore, this IgG most probably formed 
as  a  result of polyclonal B  cell activation but  not  from antigenic stimulation.  For 
example, R595 LPS stimulated the production of both 7S anti-DNP antibodies and 
7S anti-ssDNA antibodies in parallel with total IgG production. 
That athymic C57BL/6 nude mice develop as much IgG as normal mice after the 
injection of R595 LPS suggests that  the production of IgG polyclonal antibodies is 
not dependent on the presence of T  cells.  Such T-independent IgG production was 
indicated  in  prior  studies  in  vitro  and  in  newborn  mice  tested  in  vivo  (10,  30). 
However, because it is known that a few 0-bearing cells may be present in nude mice 
(31, 32) and because LPS itself may induce precursor cells to differentiate into mature 
T  cells  (33,  34),  one  cannot  completely  exclude  the  possible  involvement  of T 
lymphocytes in the effect that R595 LPS has on IgG production. The failure of  splenic 
lymphocytes from mice injected with R595 LPS 7 or 14 d previously to respond to the 
T  cell mitogen Con A argues against such a possibility. 
It is significant that the stimulation of B cells by R595 LPS in normal mice showed 
subclass restriction. Serum levels for IgG2b and IgG3 in R595 LPS,injected animals 
increased  to a  maximum  of 6  and  30  times,  respectively, that  of control, whereas 
levels of IgG1,  IgG2a,  and  IgA  did  not  change.  This  pattern  presumably reflects 
selective stimulation at the precursor-cell level, although we cannot rule out a role for 
helper or suppressor T  cell interactions with subclass-defined B-cell subsets.  Recent 
evidence that  IgG3 is the major IgG surface immunoglobulin on murine splenic B 
lymphocytes (35) as well as the principle subclass represented in immune responses to 
several carbohydrate antigens  (36)  further supports  the  notion  of subclass-specific 
regulatory mechanisms. 
In  contrast  to  its  restricted  effect  on  normal  mice,  R595  LPS  stimulated  the SHOZO IZUI, ROBERT A. EISENBERG, AND FRANK J. DIXON  335 
production of  all the IgG subclasses in athymic nude mice. Injection of nu/nu animals 
with  R595  LPS  increased  their  serum  levels  of IgG1  and  IgG2a  from  markedly 
diminished levels to concentrations approximating those found in control normals. 
On the other hand, the levels of IgG2b and IgG3 in nu/nu mice were comparable to 
those of euthymic controls, and these levels increased after R595 LPS stimulation in 
parallel fashion in both groups. That nude mice normally had low levels of IgG1 and 
IgG2a, but not IgG2b and IgG3, as relzorted here as well as previously (37, 38), and 
that nude mice with thymus grafts were reconstituted in respect to serum concentra- 
tions of IgG2a (30) suggest that the production of IgG 1 and IgG2a is more dependent 
on the presence  of functional T  cells than that of IgG2b and IgG3.  However, our 
results indicate that T cell help can be replaced with LPS in reconstituting IgG1 and 
IgG2a to at least normal levels in immunologically deficient athymic nude mice. 
Lipid A appears to be essential for LPS to stimulate IgG formation, as suggested by 
the failure of C3H/HeJ mice,  genetic low responders  to lipid A (26, 28, 29, 39), to 
form polyclonal IgG antibody after stimulation by R595 LPS. In addition, R595 LPS 
has a  particularly high content of lipid A:  70% by chemical analysis, as compared 
with 35% for PII-LPS (D. C. Morrison, personal communication). However, this fact 
alone cannot explain its  unique IgG-stimulating activity, because 5 #g R595  LPS 
induced a significant IgG response,  but  100 #g PII-LPS, which contains ~ 10 times 
lipid A,  did not. A  more likely  possibility is that the production of antibodies to 
polysaccharide O-antigen present in most LPS but not in R595 LPS may subsequently 
inhibit  the  full  expression  of lipid  A  activity. Alternatively, the  lesser degree  of 
solubility of R595  LPS than of other LPS may allow for greater quantities of R595 
LPS to localize  in tissues, particularly in lymphoid organs; if so, their contact with 
and  stimulation of B cells  in tissues  might be  increased.  However, in our related 
experiments, almost identical amounts of R595 LPS and PII-LPS localized in spleens, 
and the disappearance rates were no different up to 15 d after injection. 
Our data confirm and extend previous studies demonstrating the role of polyclonal 
B cell activators in the development of autoimmunity (4-8,  40). In contrast to the 
limited  induction  of autoimmunity by  most  preparations  of LPS,  lipid  A-rich, 
polysaccharide-free R595 LPS can induce a relatively stable state of autoimmunity in 
normal mice and also stimulate the production of IgG autoantibodies. Although these 
IgG antibodies are restricted as to subclass, this unique response  to the injection of 
R595 LPS may be, in part, comparable to the spontaneous development of autoanti- 
bodies in mice with autoimmune disease as suggested previously (6, 23). 
Summary 
The effects of five distinct bacterial lipopolysaccharides (LPS) on the induction of 
polyclonal IgM and IgG antibodies, including polyclonal autoantibody formation, 
were investigated in several strains of mice. Injections of most LPS preparations that 
contained polysaccharide transiently induced only IgM polyclonal antibodies. How- 
ever, LPS from Salmonella minnesota R595  (R595 LPS), which had a particularly high 
content of  lipid A but lacked O-antigen polysaccharide, induced a markedly prolonged 
IgM and IgG polyclonal antibody response  in mice,  including athymic nude mice, 
but not in LPS-unresponsive C3H/HeJ mice.  Polyclonal IgM and IgG production 
peaked in sera on day 8 and day 15, respectively,  and remained higher than control 
values 2 mo after the injection. The IgG induced by R595 LPS was strictly restricted 336  lgG  POLYCLONAL ANTIBODY  RESPONSE  BY LIPOPOLYSACCHARIDES 
to  IgG2b and  IgG3 subclasses  in  normal  mice.  In contrast,  in  athymic  nude  mice 
which have normally lower levels of IgG1 and  IgG2a than  normal mice, R595 LPS 
stimulated  the production of all the IgG subclasses and reconstituted  serum levels of 
IgG1  and  IgG2a up  to, but  not  higher than,  control  values  of normal  mice.  These 
findings suggest that different mechanisms regulate production of each IgG subclass 
after stimulation with LPS. 
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